News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

With Their Rights Squabble Settled, Eli Lilly and Company (LLY) and Bristol-Myers Squibb Company (BMY) Look Ahead



2/23/2010 10:35:25 AM

Seeking Alpha -- Bristol-Myers Squibb (BMY) and Eli Lilly (LLY) announced Thursday that they had settled their dispute over rights to necitumumab, formerly known as IMC-11F8, an antibody which must rank as one of the most squabbled over in recent times.

Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES